explore -WSS

explore

author：hotspot 2025-09-27 12:43:01 - browse：18396

The experimental Alzheimer’s drug lecanemab, hailed after it slowed patients’ cognitive decline in a clinical trial, may have contributed to the death in June of a patient in the study, STAT has learned.

One investigator on the study flagged the death, noting it came after the patient experienced bleeding in the brain, and concluded it was related to the drug, according to documents obtained by STAT. Eisai, the drugmaker behind lecanemab, disagreed, pointing to other possible factors, including a series of setbacks in preceding months — multiple falls, a heart attack, a respiratory infection, and mini-stroke-like events.

Though still under investigation, the death suggests that new medicines to treat Alzheimer’s, like medicines to treat anything else, will come with their own side effects and costs. It also raises the importance of waiting for the full lecanemab data before drawing conclusions based on the positive press release put out by Eisai and its partner Biogen last month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： White House Covid adviser calls on docs to combat misinformation

WSS

Redefining sustainability for the pharmaceutical industry

Akili changes sales model for its ADHD video game treatment

Free Covid tests will again be offered to all U.S. households

Readout Newsletter: Beam, Prozac, "TechBio" and more

Pfizer is about to make a big push in cancer. Will investors listen?

Patients, doctors press FTC to beef up hospital merger scrutiny

entertainment

explore

leisure time

In age of alternative facts, a scholarly course on calling out crap

White House Covid adviser calls on docs to combat misinformation

In Memoriam: Notable people who died in 2023

David Liu startup to focus on CRISPR delivery

The cancer drug shortage isn’t new — and neither are the solutions

Neuroscience renaissance leads to new crop of psychiatric drugs

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Covid’s new normal has set in amid another rise in cases

Dobbs anniversary: the lost opportunity of abortion as health care

Virtual repurposing can help discover new uses for existing drugs

Wikipedia

Senate bill would ban some hospital facility fees

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

CDC advisory group OKs chikungunya vaccine

Fed up with FDA, ALS advocates consider a take

Covid’s new normal has set in amid another rise in cases

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

knowledge

Wikipedia

focus

Wikipedia